Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor

Conditions:   Atrial Fibrillation;   Diastolic Dysfunction;   HFpEF - Heart Failure With Preserved Ejection Fraction Intervention:   Drug: As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil) Sponsor:   University of Vermont Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials